Shenzhen Leading Semiconductor Industry (603991.SH) intends to change its securities abbreviation to "Leading Shares".
Zhi Zheng Co., Ltd. (603991.SH) announced that in order to fully match the company's major asset restructuring and business transformation, and more accurately reflect the company's current business reality and long-term strategic planning, the company has revised its articles of association and changed its full name to "Shenzhen Leading Semiconductor Technology Industry Co., Ltd." According to the relevant provisions of the "Shanghai Stock Exchange Listing Rules", the company plans to change its current securities abbreviation from "Zhi Zheng Co., Ltd." to "Leading Co., Ltd.".
Shenzhen Leading Semiconductor Industry (603991.SH) announced that, in order to fully align with the business transformation following a major asset restructuring, and to more accurately reflect the current business situation and long-term strategic planning of the company, the company has revised its articles of association and changed its full name to "Shenzhen Leading Semiconductor Technology Industry Co., Ltd." According to the relevant provisions of the Shanghai Stock Exchange Listing Rules, the company intends to change its current stock abbreviation from "Shenzhen Leading Semiconductor Industry" to "Leading Shares."
Related Articles
NIngbo Boway Alloy Material (601137.SH) subsidiary plans to transfer rights to tax exemptions for the production of advanced manufacturing industry in the United States.
TONGCHENGTRAVEL Zhihu releases 2026 Museum Travel Trend Report: 1 out of every 8 sightseeing reservation users visits a museum.
Zhejiang Garden Biopharmaceutical(300401.SZ): Obtained the drug registration certificate for Apovastatin Calcium Tablets (I)
NIngbo Boway Alloy Material (601137.SH) subsidiary plans to transfer rights to tax exemptions for the production of advanced manufacturing industry in the United States.
TONGCHENGTRAVEL Zhihu releases 2026 Museum Travel Trend Report: 1 out of every 8 sightseeing reservation users visits a museum.
Zhejiang Garden Biopharmaceutical(300401.SZ): Obtained the drug registration certificate for Apovastatin Calcium Tablets (I)
